The Changing Role of Radiation in Prostate Cancer
Radiation's role continues to shift in the treatment of patients with prostate cancer.
Radiation is still a main treatment modality in the prostate cancer space, though its role continues to change and expand, according to James B. Yu, MD, MHS, associate professor at the Yale School of Medicine.
Radiation continues to be a main curative treatment for the disease in the adjuvant/salvage setting. However, it is gaining an even bigger role in patients with oligometastatic disease, which Yu described as, "just enough metastatic burden to be metastatic, but not so metastatic to be beyond the ability to obtain benefit from an aggressive treatment."
Oncology nurses can be on the frontlines of research when it comes to radiation's use in cancer care.
Key Advances in Cancer Survivorship Toxicity Management
July 15th 2022In this episode of The Vitals, Lidia Schapira, MD, FASCO, recounts highlights from the 2022 ASCO Symptoms and Survivorship track and underscores key takeaways for practitioners seeking to enhance the delivery of cancer survivorship care.
Enfortumab Vedotin Plus Pembrolizumab Improves Outcomes vs Chemo in Urothelial Cancer
April 20th 2024Patients with locally advanced or metastatic urothelial cancer treated with enfortumab vedotin plus pembrolizumab experienced a reduction in the risk for disease progression or death vs chemotherapy.
